PML promotes MHC class II gene expression by stabilizing the class II transactivator

Area of Science:

• Immunology
• Molecular Biology
• Cell Biology

Background:

• Promyelocytic leukemia (PML) nuclear bodies are nuclear dots associated with transcriptionally active genomic regions.
• Interferon-gamma (IFN-γ) is a key cytokine involved in immune responses, including the regulation of major histocompatibility complex (MHC) expression.
• MHC class II molecules are crucial for antigen presentation to T helper cells.

Purpose of the Study:

• To investigate the role of PML bodies in IFN-γ-induced MHC class II expression.
• To elucidate the molecular mechanisms by which PML influences MHC class II gene transcription.

Main Methods:

• Confocal microscopy to assess spatial proximity between PML bodies and MHC class II loci.
• siRNA-mediated knockdown of PML to evaluate its necessity for MHC II expression.
• Western blotting and proteasomal degradation assays to study CIITA stability.
• Immunoprecipitation to identify protein complexes involving PML and CIITA.

Main Results:

• IFN-γ stimulation significantly increased the spatial association between PML bodies and the MHC class II gene cluster.
• PML knockdown impaired efficient IFN-γ-induced transcription of MHC class II genes.
• PML was found to protect the class II transactivator (CIITA) from proteasomal degradation.
• PML isoform II specifically formed a stable complex with CIITA at PML bodies.

Conclusions:

• PML acts as a crucial coregulator of IFN-γ-induced MHC class II expression.
• PML stabilizes CIITA, thereby enhancing MHC class II gene transcription.
• These findings highlight a novel regulatory pathway involving PML in immune gene expression.